Drug Shortage Report for FASTURTEC
Report ID | 16581 |
Drug Identification Number | 02248416 |
Brand name | FASTURTEC |
Common or Proper name | Fasturtec 1.5mg vial powder plus 1.0mL solvent |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | RASBURICASE |
Strength(s) | 1.5MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 3 vials |
ATC code | V03AF |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2017-07-17 |
Estimated end date | 2017-09-04 |
Actual end date | 2017-08-16 |
Shortage status | Resolved |
Updated date | 2017-08-17 |
Company comments | RESOLVED/RELEASED 2017-08-16 |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-07-21 | English | Compare |
v2 | 2017-07-21 | French | Compare |
v3 | 2017-08-16 | English | Compare |
v4 | 2017-08-16 | French | Compare |
v5 | 2017-08-17 | English | Compare |
Showing 1 to 5 of 5